207_Combined course Presentations

First page Table of contents Previous page 990 Next page Last page

Background

 Cisplatin/Etoposide (CE) and Carboplatin/Paclitaxel (CP) are two of the most commonly utilized regimens for the treatment of stage III non-small cell lung cancer (NSCLC)

Made with